Eledon Pharma Analyst Ratings
Eledon Pharmaceuticals' Tegoprubart Shows Promising Trial Results and Fuels Buy Rating
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Agenus (AGEN)
Eledon Pharmaceuticals' Tegoprubart Shows Promising Clinical Advancements, Reinforcing Buy Rating and Elevated Price Target
Eledon Pharma Analyst Ratings
Eledon Pharmaceuticals Risks Shareholder Equity Dilution Amidst Private Placement and Potential Stock Issuances
Eledon Pharma Analyst Ratings
Eledon Pharmaceuticals: A Buy Rating on Breakthrough Organ Transplant Solutions
Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX), Edgewise Therapeutics (EWTX) and Eledon Pharmaceuticals (ELDN)
HC Wainwright & Co. Reiterates Buy on Eledon Pharma, Maintains $13 Price Target
Eledon Pharma Analyst Ratings
Eledon Pharmaceuticals Receives Buy Rating: Successful Tegoprubart Trials & Strong Financial Status Contribute to Positive Outlook
Promising Phase Ib Study Results Bolster Buy Rating for Eledon Pharmaceuticals: An Analysis by Rami Katkhuda
Eledon Pharma Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Shockwave Medical (SWAV), Eledon Pharmaceuticals (ELDN)
Noble Capital Markets Initiates Coverage On Eledon Pharma With Outperform Rating, Announces Price Target of $10
Eledon Pharma Analyst Ratings
Promising Clinical Trials and Future Projections Bolster Buy Rating for Eledon Pharmaceuticals
Eledon Pharma Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Eledon Pharmaceuticals (ELDN), Stereotaxis (STXS)
No Data